Mehmet Kocoglu

12PUBLICATIONS
82CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 03, 2026
Arlocabtagene autoleucel-a GPRC5D-targeted CAR T-cell therapy in heavily pretreated relapsed/refractory multiple myeloma.

|May 12, 2026
Real-World Experience With a ZUMA-1 Cohort 4 Adopted Approach to CRS and ICANS in CAR-T Recipients.

|Aug 28, 2025
Safety and efficacy of BCMA-directed chimeric antigen receptor T-cell therapy for the treatment of plasma cell leukemia.

Gliceida M Galarza Fortuna, Lauren Peres, Elena Nazarenko

|Jul 29, 2025
Defibrotide for Protecting Against and Managing Endothelial Injury in Hematologic Malignancies and COVID-19.

Edward Richardson, Clifton C Mo, Eleonora Calabretta

|Mar 15, 2025
Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma.

Rahul Banerjee, Alicia Richards, Shonali Midha

|Feb 18, 2025
Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma.

Doris K Hansen, Lauren C Peres, Danai Dima

Pageof 2

Frequent Collaborators

6 joint publications

Surbhi Sidana

6 joint publications

Joseph P McGuirk

6 joint publications

Jack Khouri

6 joint publications

Douglas W Sborov